The FDA seems to be waiting for GMO soybeans to be ready before it follows through on its promise to ban the toxic fats. A new study published in the journal Preventing Chronic Disease, available on the CDC’s website, shows that Americans are consuming much more trans fat than they realize. A federal loophole allows food companies […]
Recent regulations released by the FDA contain several provisions that are harmful to doctors, patients, and compounding pharmacists. Office Use: This is an area of the rulemaking that has garnered the biggest reaction from the compounding community. Congress and the FDA have required a patient-specific prescription for all drugs compounded, with a narrow exception if […]
Compounding has recently undergone a regulatory overhaul by Congress and the FDA. In November 2013, the Drug Quality and Security Act (DQSA) was signed in to law, amending the federal Food, Drug, and Cosmetic Act (FDCA) and overhauling the regulation of compounding. In July 2014, the FDA released rules and guidances and other documents implementing […]
Patent protection means you get to charge whatever the market will bear. In this case, it bears a 935% increase in the price tag.
Why are these approaches being ignored? Could it be because there is little profit to be made from them? Action Alert!
ObamaCare was crafted to suit the largest insurance companies, and now your tax dollars are subsidizing them.
One test per year not related to a specific illness under Medicare? So much for preventive medicine.
The USDA’s response is to talk out of both sides of their mouth. In a single press release, the USDA closes its investigation of the contamination of wheat fields in Oregon, calling it an “isolated incident,” then immediately contradicts itself by opening another investigation into contamination from genetically engineered wheat. The contamination was found at […]
The agency has responded to comments from ANH-USA activists and other stakeholders. Here’s what they’re proposing now. Action Alert! In May we reported that the FDA is currently drafting rules that implement the 2011 Food Safety Modernization Act (FSMA). As we noted then, some of the rules that have been proposed so far have brought […]
Dr. Einsteinburger, scientific director of Biosantech (no relation to any real biotech companies located in the St. Louis area), elaborates on the latest innovations by the leader in biotech.